Sokan New Materials Group Co., Ltd. (SHA:688157)

Verve Therapeutics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,767	4,376	6,027	6,984	9,687	6,607
Market Cap Growth	14.79%	-27.40%	-13.70%	-27.91%	46.63%	-
Enterprise Value	5,665	4,308	5,722	6,512	9,229	5,886
Last Close Price	37.01	27.92	38.07	43.90	60.81	41.35
PE Ratio	76.32	50.65	74.31	84.86	99.46	75.78
Forward PE	40.91	28.97	48.70	44.60	66.69	44.03
PS Ratio	7.55	5.87	10.22	13.99	19.06	15.19
PB Ratio	4.26	3.25	4.61	5.53	8.08	6.00
P/TBV Ratio	4.65	3.56	4.82	5.79	8.51	6.24
P/FCF Ratio	78.37	-	-	-	-	440.86
P/OCF Ratio	28.31	47.22	228.46	49.63	169.97	92.08
EV/Sales Ratio	7.42	5.78	9.70	13.05	18.16	13.53
EV/EBITDA Ratio	47.61	36.32	61.65	81.12	94.44	61.62
EV/EBIT Ratio	74.42	50.63	76.48	98.40	108.67	69.45
EV/FCF Ratio	76.98	-	-	-	-	392.78
Debt / Equity Ratio	0.15	0.12	0.06	0.02	0.01	0
Debt / EBITDA Ratio	1.68	1.25	0.79	0.22	0.07	0.00
Debt / FCF Ratio	2.72	-	-	-	-	0.01
Asset Turnover	0.44	0.44	0.40	0.36	0.39	0.48
Inventory Turnover	3.36	3.54	4.01	3.77	4.92	4.67
Quick Ratio	1.52	1.67	2.88	6.03	6.98	7.42
Current Ratio	1.88	2.04	3.31	6.75	7.63	7.78
Return on Equity (ROE)	6.00%	6.60%	6.09%	6.69%	8.38%	11.55%
Return on Assets (ROA)	2.74%	3.15%	3.13%	3.00%	4.10%	5.84%
Return on Capital (ROIC)	3.17%	3.68%	3.51%	3.33%	4.60%	7.03%
Return on Capital Employed (ROCE)	5.40%	6.10%	5.60%	5.10%	7.00%	7.60%
Earnings Yield	1.35%	1.97%	1.35%	1.18%	1.00%	1.32%
FCF Yield	1.28%	-1.28%	-3.07%	-1.42%	-0.52%	0.23%
Dividend Yield	0.45%	0.60%	0.41%	0.36%	0.31%	0.41%
Payout Ratio	35.26%	31.57%	30.90%	35.79%	26.97%	9.18%
Buyback Yield / Dilution	-1.60%	0.31%	-1.25%	1.00%	-14.44%	-16.21%
Total Shareholder Return	-1.16%	0.90%	-0.84%	1.36%	-14.13%	-15.80%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.